2',4'-difluoro-4-hydroxy-3-biphenylcarboxylic acid ( DrugBank: - )

1 disease
告示番号疾患名（ページ内リンク）臨床試験数
28全身性アミロイドーシス2

28. 全身性アミロイドーシス

臨床試験数 : 261 /  薬物数 : 276 - (DrugBank : 81) / 標的遺伝子数 : 68 - 標的パスウェイ数 : 178
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1EUCTR2006-001066-16-GB
(EUCTR)		25/08/201018/06/2010A randomized, double-blind, placebo-controlled, international multi-center trial ofdiflunisal on neurologic disease progression in 200 familial amyloid subjects - The effect of diflunisal on familial amyloidosisA randomized, double-blind, placebo-controlled, international multi-center trial ofdiflunisal on neurologic disease progression in 200 familial amyloid subjects - The effect of diflunisal on familial amyloidosis Hereditary neuropathic amyloidosis
MedDRA version: 11.;Level: LLT;Classification code 10019889;Term: Hereditary neuropathic amyloidosis		Trade Name: Dolobid
Product Name: diflunisal (dolobid)
INN or Proposed INN: diflunisal
Other descriptive name: 2',4'-difluoro-4-hydroxy-3-biphenylcarboxylic acid		John L. BerkNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes		140United Kingdom;Italy;Sweden
2EUCTR2006-001066-16-SE
(EUCTR)		04/01/200709/11/2006The effect of diflunisal (IND 68092) on familial amyloidosis - The Diflunisal TrialThe effect of diflunisal (IND 68092) on familial amyloidosis - The Diflunisal Trial Familial Amyloid Polyneuropathy (FAP)Trade Name: Dolobid
Product Name: diflunisal (dolobid)
INN or Proposed INN: diflunisal
Other descriptive name: 2',4'-difluoro-4-hydroxy-3-biphenylcarboxylic acid		John L. Berk, M.D.NULLNot RecruitingFemale: yes
Male: yes		200United Kingdom;Italy;Sweden